Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain

被引:27
|
作者
Gonzalez-Escalada, Alba [1 ,2 ]
Garcia-Garcia, Laura [1 ,2 ]
Viguera-Ester, Pablo [1 ,2 ]
Marin-Garcia, Patricia [1 ,2 ]
Garcia, Jesus [3 ]
Gil-de-Miguel, Angel [1 ,2 ]
Gil-Prieto, Ruth [1 ,2 ]
机构
[1] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Madrid, Spain
[2] Univ Rey Juan Carlos, Dept Immunol & Med Microbiol, Madrid, Spain
[3] Fuenlabrada Univ Hosp, Microbiol Unit, Madrid, Spain
关键词
seroprevalence; young adults; measles; rubella; mumps; B; Pertussis; Varicela-Zoster Virus; BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; VIRUS; POPULATION; CATALONIA; COUNTRIES; ASSAYS; STANDARDIZATION; EPIDEMIOLOGY; PERFORMANCE;
D O I
10.4161/hv.25127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In recent years, there has been an increase in the number of cases of certain immunopreventable diseases in our country. A high proportion of these have been recorded among the young adult population. The aim of this study was to determine the seroprevalence of antibodies against immunopreventable diseases with the greatest health impacts on the young adult population (19-39 y of age) in Madrid. We collected a total of 1,153 serum samples from healthy volunteers undergoing routine medical visits and used ELISA to determine the presence of IgG antibodies against measles, rubella, mumps, and varicella zoster, as well as Bordetella pertussis. The Pearson's 2 test was used to compare prevalences, the Mann-Whitney U test was used to compare means, and the Kruskal-Wallis test was applied for variables with more than 2 categories. Statistical significance was achieved with p values of < 0.05. The global prevalence of antibodies was 92.1% for measles, 94.4% for rubella, 88.3% for mumps, 92.8% for varicella zoster, and 70.2% for B. pertussis. No statistically significant differences were found between genders. The prevalence of antibodies against measles was more than 95% in the group of individuals born after 1986, and the percentage of individuals susceptible to rubella was less than 5% in women born after 1986. In spite of adequate vaccination coverage, in our region, a population of young adults exists who have not achieved the objectives of the WHO for the elimination of measles and congenital rubella syndrome.
引用
收藏
页码:1918 / 1925
页数:8
相关论文
共 50 条
  • [21] Seroprevalence of Antibodies Against Varicella-Zoster Virus Among Prevalent Hemodialysis Patients
    Talebi-Taher, Mahshid
    Hassanzadeh, Tina
    Ossareh, Shahrzad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (06) : 475 - 478
  • [22] HEPATITIS A, HEPATITIS B, MEASLES, MUMPS, RUBELLA AND VARICELLA SEROPREVALENCE IN TURKISH ADOLESCENT NURSING STUDENTS
    Sac, Rukiye
    Tasar, Medine Aysin
    Yalaki, Zahide
    Guneylioglu, Mustafa Muhammed
    Ozsoy, Gamze
    Karadagli, Seckin
    Gocmen, Sabir
    Akbas, Nermin
    Alioglu, Bulent
    NOBEL MEDICUS, 2019, 15 (01): : 33 - 40
  • [23] Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing
    Qing-hong Meng
    Ying Liu
    Jin-qian Yu
    Li-jun Li
    Wei Shi
    Ying-jie Shen
    Li Li
    Shi-na Zhan
    Fan Yang
    Ya-juan Wang
    Kai-hu Yao
    Scientific Reports, 8
  • [24] Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing
    Meng, Qing-hong
    Liu, Ying
    Yu, Jin-qian
    Li, Li-jun
    Shi, Wei
    Shen, Ying-jie
    Li, Li
    Zhan, Shi-na
    Yang, Fan
    Wang, Ya-Juan
    Yao, Kai-hu
    SCIENTIFIC REPORTS, 2018, 8
  • [25] Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study
    A. Domínguez
    P. Plans
    J. Costa
    N. Torner
    N. Cardenosa
    J. Batalla
    A. Plasencia
    L. Salleras
    European Journal of Clinical Microbiology and Infectious Diseases, 2006, 25 : 310 - 317
  • [26] Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study
    Dominguez, A.
    Plans, P.
    Costa, J.
    Torner, N.
    Cardenosa, N.
    Batalla, J.
    Plasencia, A.
    Salleras, L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (05) : 310 - 317
  • [27] ANTIBODIES IN YOUNG-ADULTS AND CHILDREN - CONCLUSIONS ON VACCINATIONS AGAINST RUBELLA, MEASLES, MUMPS, DIPHTHERIA AND TETANUS
    DEPILAR, CEP
    EPP, C
    HELLEIN, G
    SPIESS, H
    MONATSSCHRIFT KINDERHEILKUNDE, 1982, 130 (06) : 343 - 345
  • [28] Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubelia and varicella-zoster virus in preterm and full term newborns
    Leineweber, B
    Grote, V
    Schaad, UB
    Heininger, U
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (04) : 361 - 363
  • [29] Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients
    Chaves, TDS
    Lopes, MH
    de Souza, VAUF
    dos Santos, SD
    Pereira, LM
    Reis, AD
    David-Neto, E
    PEDIATRIC TRANSPLANTATION, 2005, 9 (02) : 192 - 196
  • [30] Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG Multiplex Bead Immunoassay
    Binnicker, Matthew J.
    Jespersen, Deborah J.
    Rollins, Leonard O.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (09) : 1524 - 1526